Table 1 Patient characteristics
Gender | |
Female | 7 (27%) |
Male | 19 (73%) |
Age (years) | |
Median | 62.5 |
Range | 24–82 |
Primary sites (no. pts.) | |
Oropharynx | 15 (57.7%) |
Hypopharynx | 8 (30.8%) |
Trans-regional | 3 (11.5%) |
(r) c/p T – Tumor size | |
0 | 1 (3.8%) |
1 | 1 (3.8%) |
2 | 9 (34.6%) |
3 | 9 (34.6%) |
4 | 6 (23.2%) |
(r) c/p N – Nodal Status | |
0 | 8 (30.8%) |
1 | 3 (11.5%) |
2a | 2 (7.7%) |
2b | 4 (15.4%) |
2c | 9 (34.6%) |
M - Metastases | |
0 | 26 (100%) |
G – Grading | |
1 | 2 (7.7%) |
2 | 14 (53.8%) |
3 | 10 (38.5%) |
Concomittant chemotherapy (no. pts.) | 13 (50%) |
Cisplatin | 12 (46.2%) |
Paclitaxel | 1 (3.8%) |